Vandortuzumab vedotin | Interleukin Related interleukin-related.com

Product Name :
Vandortuzumab vedotin

Search keywords :
Vandortuzumab

drugId :
null

Target Vo:
Tubulin

Target Vo Short Name :
Tubulin

Moa_Name:
Tubulin polymerisation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Genentech Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Prostatic Neoplasms

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MRC1 Antibody
Glucose Transporter GLUT4 Antibody (YA753)
PPAR alpha Antibody: PPAR alpha Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to PPAR alpha. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts